porcin
epidem
diarrhea
ped
highli
contagi
enter
swine
diseas
larg
econom
impact
ped
swine
industri
worldwid
made
develop
effect
ped
vaccin
necess
truncat
region
porcin
epidem
diarrhea
viru
pedv
spike
protein
suggest
candid
antigen
ped
subunit
vaccin
howev
poor
solubl
problem
protein
express
escherichia
coli
inher
problem
subunit
vaccin
low
immunogen
remain
flagellin
wide
use
fusion
partner
enhanc
immunogen
solubl
mani
difficulttoexpress
protein
howev
conjug
effect
flagellin
vari
depend
target
antigen
posit
fusion
placement
conjug
flagellin
vibrio
vulnificu
flab
nand
ctermini
evalu
abil
fusion
enhanc
solubl
immunogen
flagellin
conjug
presenc
trigger
factor
chaperon
tig
greatli
improv
solubl
fusion
protein
regardless
conjug
posit
import
flagellin
conjug
nterminu
significantli
enhanc
humor
immun
respons
compar
recombin
antigen
balbc
mice
mechan
phenomenon
investig
vitro
vivo
studi
find
provid
import
inform
develop
novel
ped
vaccin
flagellinbas
immunotherapeut
porcin
epidem
diarrhea
ped
one
catastroph
swine
diseas
character
sever
diarrhea
vomit
dehydr
even
death
mortal
rate
ped
especi
neonat
piglet
result
larg
econom
loss
swine
farm
across
globe
includ
europ
asia
usa
past
three
decad
make
develop
effect
ped
vaccin
necess
current
use
ped
vaccin
live
attenu
vaccin
lav
inactiv
vaccin
inher
problem
relat
safeti
costeffect
particular
effect
vaccin
becom
controversi
outbreak
ped
unit
state
consequ
stress
need
develop
novel
ped
vaccin
subunit
vaccin
subunit
vaccin
involv
use
antigen
compon
pathogen
bacteria
virus
could
use
vaccin
instead
entir
pathogen
despit
rel
low
immunogen
subunit
vaccin
mani
advantag
tradit
lav
includ
safeti
simplic
abil
mass
produc
e
coli
system
particular
costeffect
subunit
vaccin
import
advantag
associ
econom
object
livestock
industri
howev
candid
antigen
ped
subunit
vaccin
express
insolubl
aggreg
e
coli
suitabl
use
vaccin
although
possess
enrich
neutral
epitop
potenti
crossreact
variou
pedv
strain
overcom
low
solubl
low
immunogen
ped
subunit
vaccin
introduct
molecular
fusion
adjuv
flagellin
protein
would
necessari
flagellin
monomer
subunit
bacteri
flagella
one
mani
pathogenassoci
molecular
pattern
pamp
protein
recogn
two
germlineencod
receptor
number
innat
adapt
immun
cell
flagellin
frequent
use
molecular
fusion
adjuv
recent
decad
receptor
thought
involv
adjuv
activ
flagellin
also
use
fusion
partner
enhanc
solubl
mani
hardtoexpress
protein
howev
conjug
effect
flagellin
vari
depend
target
antigen
direct
conjug
therefor
conjug
flagellin
differ
termin
cterminu
could
influenc
solubl
immunogen
studi
conjug
flagellin
vibrio
vulnificu
flab
cor
nterminu
gener
respect
test
effect
flagellin
conjug
enhanc
solubl
improv
solubl
recombin
protein
trigger
factor
chaperon
tig
use
solubl
recombin
protein
assess
presenc
tig
also
evalu
abil
conjug
flagellin
enhanc
humor
immun
respons
balbc
mice
identifi
differ
outcom
depend
direct
fusion
underli
mechan
consequ
result
deduc
vitro
vivo
experi
observ
provid
crucial
inform
develop
novel
ped
vaccin
flagellinbas
immunotherapeut
sixweekold
femal
balbc
mice
g
purchas
samtako
korea
mice
maintain
standard
pathogenfre
condit
h
lightdark
cycl
mice
per
cage
monitor
three
time
weekli
provid
free
access
food
water
experiment
mice
divid
randomli
differ
group
immun
adapt
week
treatment
anim
experi
perform
accord
guidelin
care
use
laboratori
anim
approv
anim
ethic
committe
seoul
nation
univers
final
serum
collect
experi
mice
euthan
co
inhal
nucleotid
sequenc
spike
protein
pedv
strain
genbank
access
use
refer
synthes
partial
protein
amino
acid
gene
whole
genom
sequenc
vibrio
vulnificu
genbank
access
use
refer
synthes
flab
sequenc
codonoptim
use
tabl
codon
usag
e
coli
synthesi
genescript
usa
bioneer
korea
pcramplifi
use
variou
primer
pair
provid
tabl
nucleotid
sequenc
amplifi
pcr
use
primer
clone
vector
novagen
usa
use
nhei
xhoi
restrict
enzym
site
flab
dna
fragment
amplifi
pcr
use
bflabfxflabr
primer
clone
result
construct
digest
use
nhei
bamhi
restrict
enzym
ligat
dna
fragment
previous
pcramplifi
use
primer
flab
dna
fragment
pcramplifi
use
sflabfnflabr
primer
clone
pretreat
rsap
result
construct
contain
correct
flab
direct
digest
use
nhei
restrict
enzym
ligat
pcramplifi
dna
fragment
use
primer
express
flab
alon
flab
dna
fragment
pcramplifi
use
nflabf
xflabr
primer
clone
use
nhei
xhoi
restrict
enzym
site
pf
support
nucleotid
sequenc
end
multipl
clone
site
result
recombin
protein
contain
addit
cand
ntermin
region
dna
sequenc
result
express
vector
verifi
dideoxychain
termin
method
express
plasmid
pf
transform
e
coli
invitrogen
usa
seed
cultur
prepar
singl
coloni
recombin
e
coli
adjuv
flagellin
conjug
ped
subunit
vaccin
antigen
grown
overnight
lb
broth
contain
kanamycin
one
percent
seed
cultur
inocul
lb
broth
contain
kanamycin
grown
optic
densiti
nm
od
reach
cultur
treat
mm
iptg
induc
express
protein
interest
grown
h
shake
set
rpm
cell
harvest
disrupt
ice
sonic
sonic
usa
use
preset
program
cycl
sec
sec
amp
follow
centrifug
g
min
centrifug
supernat
collect
solubl
fraction
pellet
solubil
use
mm
triscl
urea
ph
buffer
collect
insolubl
fraction
equival
volum
solubil
buffer
versu
supernat
use
prepar
insolubl
fraction
insolubl
solubl
fraction
recombin
protein
analyz
sdspage
follow
coomassi
blue
stain
fig
insolubl
fraction
subsequ
refold
describ
previous
express
recombin
protein
presenc
chaperon
tig
transform
express
plasmid
e
coli
takara
japan
induc
express
trigger
factor
chaperon
tig
seed
cultur
prepar
inocul
singl
coloni
lb
broth
contain
kanamycin
chloramphenicol
overnight
tig
express
induct
recombin
protein
one
percent
seed
cultur
inocul
lb
broth
supplement
mgml
larabinos
chloramphenicol
kanamycin
od
reach
point
cell
cool
min
subsequ
induc
mm
iptg
h
cell
disrupt
process
describ
insolubl
solubl
fraction
recombin
protein
analyz
sdspage
follow
coomassi
blue
stain
fig
band
densiti
recombin
protein
measur
use
imag
lab
softwar
biorad
laboratori
fig
solubl
fraction
express
presenc
tig
purifi
use
affin
chromatographi
ni
nta
column
purifi
sampl
dialyz
phosphat
buffer
salin
pb
three
time
subsequ
concentr
use
amicon
centrifug
filter
merck
germani
contamin
lipopolysaccharid
lp
remov
use
endotoxin
remov
spin
column
thermo
scientif
usa
residu
lp
content
recombin
protein
determin
use
toxinsensor
chromogen
lal
endotoxin
assay
kit
genescript
usa
lp
level
recombin
protein
euml
eu
per
dose
cell
kctc
korea
seed
per
well
plate
spl
korea
incub
day
dulbecco
modifi
eagl
medium
invitrogen
usa
supplement
fetal
bovin
serum
gibco
usa
atmospher
contain
co
cell
cultiv
overnight
without
fb
subsequ
stimul
differ
concentr
recombin
protein
h
supernat
harvest
cytokin
level
quantifi
use
enzymelink
immunosorb
assay
elisa
kit
cusabio
china
sixweekold
balbc
mice
n
inject
intraperiton
pmol
recombin
protein
pb
f
per
mous
total
group
total
n
sera
collect
h
postinject
intrapetros
vein
dispos
syring
deliv
steril
tube
serum
separ
centrifug
rpm
min
use
serum
separ
tube
bd
microtain
usa
cytokin
level
analyz
use
elisa
kit
invitrogen
usa
cusabio
china
respect
sixweekold
balbc
mice
n
immun
intramuscularli
pmol
recombin
protein
per
mous
total
group
total
n
three
time
interv
adapt
cfa
ifa
mix
antigen
prime
boost
mice
respect
blood
sampl
collect
day
sacrific
intrapetros
vein
dispos
syring
deliv
steril
tube
serum
separ
centrifug
rpm
min
use
serum
separ
tube
bd
microtain
usa
detect
igg
level
sera
analyz
elisa
immunopl
spl
korea
coat
purifi
recombin
carbon
data
present
mean
standard
error
mean
sem
statist
signific
assess
use
oneway
analysi
varianc
anova
post
hoc
tukey
multipl
comparison
test
truncat
region
amino
acid
pedv
spike
protein
contain
neutral
epitop
support
crossprotect
among
nonsindel
pedv
strain
chosen
target
antigen
bacteri
flagellin
vibrio
vulnificu
flab
use
fusion
adjuv
candid
flab
fuse
cor
nterminu
gener
respect
fig
nucleotid
sequenc
encod
recombin
protein
f
insert
express
vector
support
hexahistidin
tag
flank
nand
cterminu
target
protein
enhanc
purif
effici
bamhi
nhei
restrict
enzym
site
use
gener
sequenc
f
link
two
amino
acid
glyser
serser
respect
genet
codon
optim
facilit
express
e
coli
transform
express
vector
e
coli
induc
express
iptg
cell
disrupt
sonic
solubl
lysat
separ
insolubl
lysat
enhanc
solubl
recombin
protein
deem
import
factor
plan
util
solubl
lysat
experi
assess
solubl
express
solubl
insolubl
fraction
recombin
protein
confirm
sdspage
follow
coomassi
blue
stain
express
almost
entir
insolubl
protein
flagellin
express
solubl
protein
fig
c
contrast
express
mostli
insolubl
protein
express
solubl
protein
trigger
factor
chaperon
tig
use
enhanc
solubl
shown
assist
protein
fold
protect
long
hydrophob
nascent
chain
synthesi
initi
fold
stage
cotransform
tig
express
vector
fig
e
coli
togeth
target
protein
express
vector
target
protein
induc
ad
iptg
presenc
tig
alreadi
induc
larabinos
addit
condit
express
solubl
protein
contrast
almost
entir
express
solubl
protein
fig
interestingli
total
amount
express
time
higher
flagellin
appear
express
well
solubl
form
without
tig
assist
target
protein
solubl
insolubl
fraction
also
confirm
western
blot
analysi
use
antihistag
antibodi
supplementari
fig
data
reveal
solubl
express
pattern
among
target
protein
similar
tendenc
coomassi
blue
stain
result
fig
experi
purifi
solubl
lysat
recombin
protein
util
ni
nta
affin
chromatographi
subsequ
remov
endotoxin
confirm
sdspage
follow
coomassi
blue
stain
fig
c
repres
band
recombin
protein
appear
appropri
molecular
weight
locat
iptginduc
whole
cell
lysat
lane
lane
fig
compar
iptg
noninduc
whole
cell
lysat
lane
lane
fig
puriti
f
respect
tabl
due
difficulti
purifi
solubl
lysat
insolubl
aggreg
solubil
refold
subsequ
purifi
describ
previous
flagellin
adjuv
effect
humor
immun
respons
ped
antigen
evalu
mous
serum
igg
level
immun
five
group
mice
immun
three
time
intramuscularli
pb
pmol
mixtur
interv
sera
collect
week
postinject
igg
level
evalu
indirect
elisa
fig
interestingli
immun
group
significantli
higher
level
igg
iga
compar
group
week
fig
e
sera
collect
week
postinject
similar
tendenc
sera
fig
c
also
evalu
serum
titer
indic
type
immun
respons
respect
week
postinject
data
express
ratio
fig
show
group
domin
respons
respons
apart
one
mous
mice
immun
group
also
domin
respons
respons
interestingli
mice
immun
mixtur
domin
respons
respons
fig
flagellin
shown
highli
potent
adjuv
number
innat
adapt
immun
cell
interpret
differ
igg
outcom
among
variou
group
receiv
flagellin
adjuv
use
epitheli
cell
line
express
constitut
supplementari
fig
f
effect
induc
significantli
alon
nm
nm
treatment
f
induc
significantli
treatment
similar
pattern
observ
fig
evid
differ
abil
induc
indepth
analysi
verifi
recombin
protein
abil
activ
pathway
vivo
mice
inject
intraperiton
equival
molar
valu
recombin
protein
sera
analyz
elisa
detect
marker
activ
data
reveal
f
treatment
induc
stronger
serum
level
compar
treatment
h
fig
consist
vitro
data
tendenc
induc
higher
level
serum
level
lower
f
stimul
profil
recombin
protein
also
confirm
report
system
similar
tendenc
confirm
supplementari
fig
flagellin
recogn
transmembran
receptor
cell
surfac
also
cytosol
receptor
flagellin
adjuv
effect
humor
immun
respons
influenc
activ
receptor
therefor
also
sought
determin
abil
recombin
protein
activ
cytosol
receptor
measur
respons
cytokin
sera
interestingli
group
serum
level
significantli
higher
group
h
fig
similar
pattern
also
observ
h
flagellin
frequent
use
molecular
adjuv
conjug
variou
antigen
howev
adjuv
effect
flagellin
vari
depend
target
antigen
posit
conjug
studi
conjug
flagellin
cterminu
pedv
antigen
evalu
abil
enhanc
solubl
antigenspecif
humor
immun
respons
express
recombin
protein
e
coli
system
mani
advantag
term
cost
yield
scalabl
howev
express
e
coli
often
lead
protein
interest
form
biolog
inact
aggreg
known
inclus
bodi
ib
despit
enclos
neutral
epitop
ped
subunit
vaccin
candid
antigen
includ
amino
acid
amino
acid
coe
amino
acid
region
pedv
spike
protein
prone
express
ib
although
ib
refold
sever
method
better
express
recombin
protein
solubl
form
prevent
ib
format
first
place
variou
approach
enhanc
solubl
recombin
protein
includ
conjug
solubilityenhanc
fusion
partner
protein
optim
protein
express
adjust
physiolog
condit
host
cell
test
whether
flagellin
fusion
could
enhanc
solubl
recombin
pedv
antigen
presenc
absenc
trigger
factor
chaperon
tig
shown
fig
c
previou
studi
major
fraction
express
ib
contrast
express
solubl
protein
mainli
express
ib
data
suggest
flagellin
conjug
cterminu
improv
solubl
e
coli
express
system
without
tig
express
improv
solubl
recombin
protein
trigger
factor
chaperon
tig
shown
assist
protein
fold
synthesi
initi
fold
process
introduc
coexpress
respect
protein
interest
contrast
solubl
express
solubl
protein
fig
suggest
flagellin
conjug
also
improv
solubl
recombin
protein
presenc
tig
furthermor
coexpress
tig
amelior
solubl
respect
take
result
account
flagellin
conjug
chaperon
tig
coexpress
increas
solubl
recombin
protein
interestingli
despit
similar
molecular
weight
total
amount
express
approxim
higher
presenc
absenc
tig
respect
fig
differ
protein
level
suggest
ntermin
flagellin
sequenc
may
offer
effici
translat
initi
result
increas
product
fact
gener
accept
fusion
solubl
enhanc
nterminu
target
protein
enabl
effici
translat
initi
make
favor
choic
solubl
express
ctermin
fusion
conjug
flagellin
cterminu
improv
solubl
express
comparison
ntermin
conjug
alon
absenc
tig
fig
c
tig
enhanc
solubl
recombin
protein
assist
protein
fold
process
protein
prone
aggreg
includ
coe
region
pedv
spike
protein
otherwis
total
insolubl
express
solubl
protein
assist
tig
contrast
condit
lack
tig
rel
lower
capac
fold
recombin
protein
correctli
make
solubl
protein
therefor
rapid
translat
absenc
tig
thought
produc
ib
rather
solubl
protein
spite
total
protein
express
level
higher
protein
level
shown
fig
tabl
f
underw
purif
result
puriti
respect
howev
purifi
remark
lower
express
yield
purifi
f
differ
band
intens
solubl
purifi
fraction
reveal
signific
amount
target
protein
loss
purif
process
lane
fig
infer
bound
nand
ctermini
difficult
access
ni
metal
ion
purif
process
protect
piglet
main
contributor
substanti
econom
loss
imper
immun
sow
establish
passiv
immun
piglet
via
colostrummilk
therefor
enhanc
pedvspecif
humor
immun
respons
prerequisit
ped
vaccin
develop
flagellin
use
fusion
adjuv
broad
rang
recombin
antigen
past
decad
howev
rel
studi
assess
effect
flagellin
fusion
posit
adjuv
activ
therefor
test
abil
induc
humor
immun
respons
mice
interestingli
shown
fig
e
confirm
flagellin
exert
differenti
adjuv
effect
depend
conjug
posit
refer
antibodi
fig
infer
neutral
antibodi
pedv
neutral
titer
posit
correl
indirect
elisa
result
use
produc
e
coli
coat
protein
use
complet
freund
adjuv
cfa
incomplet
freund
adjuv
ifa
togeth
conjug
vaccin
system
mice
immun
experi
equal
basal
adjuv
fig
expect
addit
adjuv
effect
flagellin
could
enhanc
antigen
basal
freund
adjuv
effect
flagellin
shown
enorm
potenc
adjuv
number
innat
adapt
immun
cell
evalu
abil
recombin
protein
activ
interpret
differ
igg
outcom
among
variou
flagellin
adjuv
group
shown
fig
flagellin
regardless
whether
conjug
activ
pathway
particular
f
alon
activ
pathway
significantli
higher
level
level
achiev
base
nm
treatment
data
activ
tendenc
also
confirm
vivo
fig
superior
abil
induc
igg
rel
mixtur
may
result
effect
conjug
fact
conjug
immunopotenti
antigen
demonstr
elicit
stronger
immun
respons
nonconjug
separ
treatment
mani
previou
research
investig
stronger
respons
occur
conjug
ensur
deliveri
uptak
antigen
immunopotenti
antigen
present
cell
assur
potenti
antigenspecif
immun
respons
inde
conjug
flagellin
variou
antigen
shown
provid
stronger
antigenspecif
humor
immun
respons
separ
mixtur
cell
innat
immun
system
equip
two
germlineencod
receptor
detect
flagellin
present
flagel
bacteria
transmembran
receptor
detect
extracellular
flagellin
thu
activ
number
innat
adapt
immun
cell
via
method
secret
proinflammatori
cytokin
inject
virul
factor
contain
flagellin
invad
microb
result
flagellin
found
within
cytosol
macrophag
recogn
cytosol
receptor
support
stronger
pathogen
kill
environ
pyroptosi
role
two
receptor
particular
flagellin
adjuv
effect
suggest
complementari
singl
knockout
either
pathway
interfer
adjuv
flagellin
doubleknockout
result
signific
reduct
adjuv
flagellin
howev
pathway
may
interfer
flagellin
adjuv
presenc
intact
li
w
et
al
demonstr
flagellin
lack
abil
activ
due
point
mutat
induc
significantli
higher
antigenspecif
serum
igg
titer
wildtyp
flagellin
use
adjuv
model
antigen
mice
aj
mice
natur
partial
defici
display
higher
igg
respons
ovalbumin
ova
mice
immun
mixtur
ova
flagellin
data
reveal
treatment
induc
significantli
higher
level
repres
cytokin
pathway
f
treatment
mice
fig
suggest
superior
abil
activ
pathway
may
interfer
flagellin
adjuv
reduc
serum
igg
despit
advantag
conjug
form
flagellin
show
varieti
abil
activ
cognat
receptor
depend
conjug
statu
fact
sever
report
assess
effect
direction
flagellin
fusion
bioactiv
exampl
flagellin
conjug
cterminu
protein
activ
pathway
potent
counterpart
wherea
flagellin
conjug
nterminu
stimul
pathway
significantli
counterpart
even
flagellin
alon
specul
receptor
bind
domain
flagellin
may
influenc
presenc
protein
caus
bind
domain
expos
bind
domain
f
evalu
adjuv
effect
flagellin
induct
system
humor
immun
respons
fig
though
mani
studi
immun
sow
intramuscular
rout
induct
virusspecif
iga
colostrummilk
result
mucos
immun
import
factor
term
lactogen
immun
work
use
target
anim
howev
crucial
develop
antigen
effect
vaccin
studi
conjug
flagellin
vibrio
vulnificu
flab
cterminu
pedv
antigen
evalu
abil
improv
protein
solubl
antigenspecif
humor
immun
respons
abil
conjug
immunopotenti
antigen
enhanc
perform
vaccin
confirm
conjug
flagellin
improv
solubl
recombin
protein
combin
chaperon
tig
flagellin
conjug
improv
solubl
protein
howev
flagellin
shown
good
candid
enhanc
antigen
solubl
protein
prone
form
ib
conjug
flagellin
nterminu
enhanc
humor
immun
respons
type
flagellin
assist
howev
flagellin
conjug
nterminu
antigen
eg
hiv
hpv
guarante
improv
antigenspecif
humor
respons
flagellin
prefer
activ
posit
differ
depend
conjug
antigen
rather
suggest
flagellinconjug
antigen
inferior
abil
activ
may
good
candid
induc
increas
antigenspecif
humor
immun
respons
furthermor
respons
domin
rather
induct
repres
immun
respons
respect
seem
inher
abil
induc
immun
respons
fig
contrast
flagellin
alon
induc
suggest
flagellin
skew
type
immun
respons
cellderiv
cytokin
import
gener
iga
mucos
site
expect
addit
advantag
util
mucos
vaccin
find
provid
crucial
inform
ration
design
ped
vaccin
flagellinbas
immunotherapeut
